COMMUNITY HEALTH SYSTEMS INC Earnings Per Share Disclosure
12. EARNINGS PER SHARE
The following table sets forth the components of the denominator for the computation of basic and diluted earnings (loss) per share for net income (loss) attributable to Community Health Systems, Inc. stockholders:
|
|
Year Ended December 31, |
|
|||||||||
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Weighted-average number of shares outstanding — basic |
|
|
133,564,227 |
|
|
|
132,101,768 |
|
|
|
130,445,677 |
|
Effect of dilutive securities: |
|
|
|
|
|
|
|
|
|
|||
Restricted stock awards |
|
|
737,970 |
|
|
|
— |
|
|
|
— |
|
Employee stock options |
|
|
1,930 |
|
|
|
— |
|
|
|
— |
|
Other equity-based awards |
|
|
708,113 |
|
|
|
— |
|
|
|
— |
|
Weighted-average number of shares outstanding — diluted |
|
|
135,012,240 |
|
|
|
132,101,768 |
|
|
|
130,445,677 |
|
The Company generated a net loss attributable to Community Health Systems, Inc. stockholders during the years ended December 31, 2024 and 2023, so the effect of dilutive securities is not considered because their effect would be antidilutive. If the Company had generated net income, the effect of stock awards and options on the diluted shares calculation would have been an increase of 1,333,424 shares and 422,487 shares during the years ended December 31, 2024 and 2023, respectively.
|
|
Year Ended December 31, |
|
|||||||||
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Dilutive securities outstanding not included in the computation of earnings |
|
|
|
|
|
|
|
|
|
|||
Employee stock options and restricted stock awards |
|
|
5,336,393 |
|
|
|
4,702,416 |
|
|
|
6,210,811 |
|
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 19, 2026 | Showing above |
| 2024 | Feb 19, 2025 | |
| 2023 | Feb 21, 2024 | |
| 2022 | Feb 17, 2023 | |
| 2021 | Feb 17, 2022 | |
| 2020 | Feb 18, 2021 | |
| 2019 | Feb 20, 2020 | |
| 2018 | Feb 21, 2019 | |
| 2017 | Feb 28, 2018 | |
| 2016 | Feb 21, 2017 | |
| 2015 | Feb 17, 2016 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.